Justyna Sakowska
Overview
    Explore the profile of Justyna Sakowska including associated specialties, affiliations and a list of published articles.
          
  Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
  
  
  Snapshot
          Snapshot
              Articles
              18
            
            
              Citations
              184
            
            
              Followers
              0
            
  
  Related Specialties
          Related Specialties
  Top 10 Co-Authors
          Top 10 Co-Authors
  Published In
          
        
        
        
  Affiliations
        Affiliations
    Soon will be listed here.
  
  Recent Articles
          1.
        
    
    Zielinski M, Sakowska J, Iwaszkiewicz-Grzes D, Gliwinski M, Hennig M, Zalinska M, et al.
  
  
    Int Immunopharmacol
    . 2024 Mar;
          132:111919.
    
    PMID: 38554443
  
  
          An imbalance between exaggerated autoaggressive T cell responses, primarily CD8 + T cells, and impaired tolerogenic mechanisms underlie the development of type 1 diabetes mellitus. Disease-modifying strategies, particularly immunotherapy focusing...
      
2.
        
    
    Santosh Nirmala S, Kayani K, Gliwinski M, Hu Y, Iwaszkiewicz-Grzes D, Piotrowska-Mieczkowska M, et al.
  
  
    Front Immunol
    . 2024 Jan;
          14:1321228.
    
    PMID: 38283365
  
  
          The initial idea of a distinct group of T-cells responsible for suppressing immune responses was first postulated half a century ago. However, it is only in the last three decades...
      
3.
        
    
    Sakowska J, Glasner P, Dukat-Mazurek A, Rydz A, Zielinski M, Pellowska I, et al.
  
  
    Transpl Immunol
    . 2023 May;
          79:101852.
    
    PMID: 37196866
  
  
          Background: Corneal transplantations (CTXs) are a vision-saving procedure. Routinely, while CTXs' survival rates remain high, the risk of graft failure increases significantly for repeated CTXs. The reason is an alloimmunization...
      
4.
        
    
    Cezary Czarnogorski M, Sakowska J, Maziewski M, Zielinski M, Piekarska A, Obuchowski I, et al.
  
  
    Immun Ageing
    . 2022 Nov;
          19(1):51.
    
    PMID: 36324179
  
  
          Background: Ageing is a complex phenomenon that leads to decreased proliferative activity, loss of function of the cells, and cellular senescence. Senescence of the immune system exacerbates individual's immune response,...
      
5.
        
    
    Piotrowska M, Zielinski M, Tylicki L, Biedunkiewicz B, Kubanek A, Slizien Z, et al.
  
  
    Front Immunol
    . 2022 Aug;
          13:832924.
    
    PMID: 35935974
  
  
          Clinical Trial Registration Number: www.ClinicalTrials.gov, identifier: NCT04 905 862.
      
6.
        
    
    Stefanska K, Tomaszewicz M, Debska-Zielkowska J, Zamkowska D, Piekarska K, Sakowska J, et al.
  
  
    Front Immunol
    . 2022 Aug;
          13:868175.
    
    PMID: 35911739
  
  
          Hypothesis: The activity of natural killer (NK) cells is considered an important factor for the tolerance of the fetus during pregnancy. The complications of pregnancy, such as hypertensive disorders (HDP),...
      
7.
        
    
    Sakowska J, Arcimowicz L, Jankowiak M, Papak I, Markiewicz A, Dziubek K, et al.
  
  
    Front Immunol
    . 2022 May;
          13:793234.
    
    PMID: 35634292
  
  
          Autoimmune disease results from the immune response against self-antigens, while cancer develops when the immune system does not respond to malignant cells. Thus, for years, autoimmunity and cancer have been...
      
8.
        
    
    Zielinski M, Zalinska M, Iwaszkiewicz-Grzes D, Gliwinski M, Hennig M, Jazwinska-Curyllo A, et al.
  
  
    Diabetes Obes Metab
    . 2022 Apr;
          24(8):1534-1543.
    
    PMID: 35441440
  
  
          Aims: Monotherapy with autologous expanded CD4 CD25 CD127 T regulatory cells (Tregs) or rituximab has been documented to slow disease progression in patients with recent-onset type 1 diabetes mellitus (T1DM)....
      
9.
        
    
    Skrzypkowska M, Stasiak M, Sakowska J, Chmiel J, Maciejewska A, Bucinski A, et al.
  
  
    Rheumatol Int
    . 2022 Feb;
          42(4):609-619.
    
    PMID: 35179632
  
  
          Rheumatoid arthritis is a severe chronic autoimmune disorder that results from pathological activation of immune cells and altered cytokine/chemokine network. The aim of our study was to evaluate concentrations of...
      
10.
        
    
    Piekarska K, Urban-Wojciuk Z, Kurkowiak M, Pelikant-Malecka I, Schumacher A, Sakowska J, et al.
  
  
    Nat Commun
    . 2022 Feb;
          13(1):856.
    
    PMID: 35165293
  
  
          Cell-based immunotherapies can provide safe and effective treatments for various disorders including autoimmunity, cancer, and excessive proinflammatory events in sepsis or viral infections. However, to achieve this goal there is...